Background: Best practise care optimises survival and quality of life in patients with pancreatic cancer (PC), but there is evidence of variability in management and suboptimal care for some patients. Monitoring practise is necessary to underpin improvement initiatives. We aimed to develop a core set of quality indicators that measure quality of care across the disease trajectory. Methods: A modified, three-round Delphi survey was performed among experts with wide experience in PC care across three states in Australia. A total of 107 potential quality indicators were identified from the literature and divided into five areas: diagnosis and staging, surgery, other treatment, patient management and outcomes. A further six indicators were adde...
Background: The aim of this systematic review is to examine patient-reported outcome measures (PROMs...
A multi-method approach was taken to examine QoL in pancreatic cancer. An in-depth study based upon ...
Objectives: Despite pancreatic cancer being the fifth highest cause of cancer death in developed reg...
Background: Best practise care optimises survival and quality of life in patients with pancreatic ca...
BACKGROUND:Best practise care optimises survival and quality of life in patients with pancreatic can...
Background: This study: (i) assessed compliance with a consensus set of quality indicators (QIs) in ...
Objectives: To develop a composite score for the quality of care for patients with pancreatic cancer...
Aim Overall 5-year survival for pancreatic cancer is ~5%. Optimising the care that pancreatic cancer...
AIM: Overall 5-year survival for pancreatic cancer is ∼5%. Optimizing the care that pancreatic cance...
BACKGROUND: Patient-reported outcomes (PROs) are amongst the most relevant outcome measures in pancr...
BACKGROUND: The development, monitoring, and reporting of indicator measures that describe standard ...
Background:The development, monitoring, and reporting of indicator measures that describe standard o...
The development, monitoring, and reporting of indicator measures that describe standard of care prov...
Executive Summary and Key RecommendationsThis Pancreatic Cancer Audit assesses the diagnosis, treatm...
Objective: To calculate and compare adherence to pancreatic cancer care quality indicators and rela...
Background: The aim of this systematic review is to examine patient-reported outcome measures (PROMs...
A multi-method approach was taken to examine QoL in pancreatic cancer. An in-depth study based upon ...
Objectives: Despite pancreatic cancer being the fifth highest cause of cancer death in developed reg...
Background: Best practise care optimises survival and quality of life in patients with pancreatic ca...
BACKGROUND:Best practise care optimises survival and quality of life in patients with pancreatic can...
Background: This study: (i) assessed compliance with a consensus set of quality indicators (QIs) in ...
Objectives: To develop a composite score for the quality of care for patients with pancreatic cancer...
Aim Overall 5-year survival for pancreatic cancer is ~5%. Optimising the care that pancreatic cancer...
AIM: Overall 5-year survival for pancreatic cancer is ∼5%. Optimizing the care that pancreatic cance...
BACKGROUND: Patient-reported outcomes (PROs) are amongst the most relevant outcome measures in pancr...
BACKGROUND: The development, monitoring, and reporting of indicator measures that describe standard ...
Background:The development, monitoring, and reporting of indicator measures that describe standard o...
The development, monitoring, and reporting of indicator measures that describe standard of care prov...
Executive Summary and Key RecommendationsThis Pancreatic Cancer Audit assesses the diagnosis, treatm...
Objective: To calculate and compare adherence to pancreatic cancer care quality indicators and rela...
Background: The aim of this systematic review is to examine patient-reported outcome measures (PROMs...
A multi-method approach was taken to examine QoL in pancreatic cancer. An in-depth study based upon ...
Objectives: Despite pancreatic cancer being the fifth highest cause of cancer death in developed reg...